Gabor Heltovics, SERDA Therapeutics - Innovative Enzymatic Wound Debridement | LSI USA '25

SERDA Therapeutics is a pioneering biopharmaceutical company focused on developing innovative therapies to treat neurodegenerative diseases, leveraging cutting-edge technology and extensive research to improve patient outcomes. Learn more: https://serda-therapeutics.com
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach